drugset / Trial / NCT04917588

Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation

NCT04917588 ↗

Completed 114 enrolled Croma-Pharma GmbH
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, open-label, multicentre, randomized study conducted to evaluate the effectiveness, safety and long-term safety of Saypha® FILLER Lidocaine for lip augmentation.

Timeline

Start
2020-07-28
Primary completion
2020-12-14
Completion
2022-04-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Saypha® FILLER Lidocaine Unknown — Other

Indications